Next Generation Sequencing Testing (NGS)
This is a contract result notice, not an open opportunity. Details from the official award data.
The procurement contact named on the official notice.
NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC).
CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs).
These require NGS QC testing services that meet specific regulatory requirements.
Make the case to bid
Reveal who to approach at NHS Blood and Transplant, and generate a go-to-market strategy from their news, accounts and people.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- ocds-h6vhtk-0514f8
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 059773-2026
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
NHS Blood and Transplant’s tender network
Assembling the network…